122 related articles for article (PubMed ID: 28161704)
1. Serum-Derived Hyaluronan-Associated Protein Is a Novel Biomarker for Inflammatory Bowel Diseases.
Yamaguchi Y; Noda H; Okaniwa N; Adachi K; Shinmura T; Nakagawa S; Ebi M; Ogasawara N; Funaki Y; Zhuo L; Kimata K; Sasaki M; Kasugai K
Digestion; 2017; 95(2):146-155. PubMed ID: 28161704
[TBL] [Abstract][Full Text] [Related]
2. Bidirectional Regulation of Circadian Disturbance and Inflammation in Inflammatory Bowel Disease.
Liu X; Yu R; Zhu L; Hou X; Zou K
Inflamm Bowel Dis; 2017 Oct; 23(10):1741-1751. PubMed ID: 28902123
[TBL] [Abstract][Full Text] [Related]
3. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan (HA) and serum-derived hyaluronan-associated protein (SHAP)-HA complex as predictive markers of cervical ripening in premature labor.
Kishida T; Yabushita H; Wakatsuki A; Zhuo L; Kimata K
Connect Tissue Res; 2008; 49(2):105-8. PubMed ID: 18382897
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease.
Gironella M; Iovanna JL; Sans M; Gil F; Peñalva M; Closa D; Miquel R; Piqué JM; Panés J
Gut; 2005 Sep; 54(9):1244-53. PubMed ID: 15870231
[TBL] [Abstract][Full Text] [Related]
6. Role of serum-derived hyaluronan-associated protein-hyaluronan complex in ovarian cancer.
Obayashi Y; Yabushita H; Kanyama K; Noguchi M; Zhuo L; Kimata K; Wakatsuki A
Oncol Rep; 2008 May; 19(5):1245-51. PubMed ID: 18425383
[TBL] [Abstract][Full Text] [Related]
7. Role of Lymphatic Deficiency in the Pathogenesis and Progression of Inflammatory Bowel Disease to Colorectal Cancer in an Experimental Mouse Model.
Daley SK; Witte MH; Washington J; Bernas M; Kiela P; Thorn J; Tanoue N; Alexander JS
Inflamm Bowel Dis; 2019 Nov; 25(12):1919-1926. PubMed ID: 31173626
[TBL] [Abstract][Full Text] [Related]
8. Relationship between levels of angiogenic and lymphangiogenic factors and the endoscopic, histological and clinical activity, and acute-phase reactants in patients with inflammatory bowel disease.
Algaba A; Linares PM; Fernández-Contreras ME; Ordoñez A; Trápaga J; Guerra I; Chaparro M; de la Poza G; Gisbert JP; Bermejo F
J Crohns Colitis; 2013 Dec; 7(11):e569-79. PubMed ID: 23642997
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease.
Crowe JS; Roberts KJ; Carlton TM; Maggiore L; Cubitt MF; Clare S; Harcourt K; Reckless J; MacDonald TT; Ray KP; Vossenkämper A; West MR
Sci Rep; 2018 Mar; 8(1):4941. PubMed ID: 29563546
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin attenuates intestinal inflammation and promotes tissue regeneration.
Nakamura S; Sho M; Koyama F; Ueda T; Nishigori N; Inoue T; Nakamoto T; Fujii H; Yoshikawa S; Inatsugi N; Nakajima Y
Scand J Gastroenterol; 2015; 50(9):1094-102. PubMed ID: 25861881
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan (HA) deposition precedes and promotes leukocyte recruitment in intestinal inflammation.
Kessler S; Rho H; West G; Fiocchi C; Drazba J; de la Motte C
Clin Transl Sci; 2008 May; 1(1):57-61. PubMed ID: 20443819
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of serotonin reuptake transporter gene expression in healing colonic mucosa in presence of remaining low-grade inflammation in ulcerative colitis.
Tada Y; Ishihara S; Kawashima K; Fukuba N; Sonoyama H; Kusunoki R; Oka A; Mishima Y; Oshima N; Moriyama I; Yuki T; Ishikawa N; Araki A; Harada Y; Maruyama R; Kinoshita Y
J Gastroenterol Hepatol; 2016 Aug; 31(8):1443-52. PubMed ID: 26676714
[TBL] [Abstract][Full Text] [Related]
13. High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis.
Holgersen K; Kutlu B; Fox B; Serikawa K; Lord J; Hansen AK; Holm TL
J Crohns Colitis; 2015 Jun; 9(6):492-506. PubMed ID: 25795566
[TBL] [Abstract][Full Text] [Related]
14. The SHAP-HA complex in sera from patients with rheumatoid arthritis and osteoarthritis.
Kida D; Yoneda M; Miyaura S; Ishimaru T; Yoshida Y; Ito T; Ishiguro N; Iwata H; Kimata K
J Rheumatol; 1999 Jun; 26(6):1230-8. PubMed ID: 10381035
[TBL] [Abstract][Full Text] [Related]
15. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function.
de la Motte CA; Hascall VC; Drazba J; Bandyopadhyay SK; Strong SA
Am J Pathol; 2003 Jul; 163(1):121-33. PubMed ID: 12819017
[TBL] [Abstract][Full Text] [Related]
16. Constitutive expression of MMP9 in intestinal epithelium worsens murine acute colitis and is associated with increased levels of proinflammatory cytokine Kc.
Liu H; Patel NR; Walter L; Ingersoll S; Sitaraman SV; Garg P
Am J Physiol Gastrointest Liver Physiol; 2013 May; 304(9):G793-803. PubMed ID: 23471340
[TBL] [Abstract][Full Text] [Related]
17. The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study.
Yarur AJ; Jain A; Sussman DA; Barkin JS; Quintero MA; Princen F; Kirkland R; Deshpande AR; Singh S; Abreu MT
Gut; 2016 Feb; 65(2):249-55. PubMed ID: 25670812
[TBL] [Abstract][Full Text] [Related]
18. A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
Vergnolle N; Cellars L; Mencarelli A; Rizzo G; Swaminathan S; Beck P; Steinhoff M; Andrade-Gordon P; Bunnett NW; Hollenberg MD; Wallace JL; Cirino G; Fiorucci S
J Clin Invest; 2004 Nov; 114(10):1444-56. PubMed ID: 15545995
[TBL] [Abstract][Full Text] [Related]
19. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
20. The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease.
Lu F; Fernandes SM; Davis AE
Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G878-83. PubMed ID: 20338925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
